Steve H. Kanzer

Filings by Steve H. Kanzer span 2 companies, the busiest being Theriva Biologics, Inc. and Soligenix, Inc. The record holds 119 filings, for trades running from 20 January 2006 to 30 April 2014.

Both buying and selling appear: 113 purchases worth €5.2M, against 3 sales worth €5.7M. No amount is published for 6 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants and 1 option exercise. So far in 2014, the count stands at no purchases and 3 sales.

The median purchase comes to €5,757.

The record was last updated on 2 May 2014 with an open-market sale (€5.2M) in Theriva Biologics, Inc. The most recent open-market purchase was published on 15 April 2008, 6,765 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.